GTM-M3M9CW6
Skip to main content
  1. Ana Sayfa >
  2. Fujitsu Hakkında >
  3. Vaka İncelemeleri>
  4. The Technical Computing Solution TC Cloud supports RCAST to develop new drugs by analytical simulations

The Technical Computing Solution TC Cloud supports RCAST to develop new drugs by analytical simulations

"We seek to develop breakthrough drugs by integrating the accumulated drug discovery research outcomes of academia with those of pharmaceutical companies derived from the analytical simulation on cloud."

Tatsuhiko Kodama Professor, RCAST, The University of Tokyo

Cloud service enables ‘in Silico’ drug discovery.

Customer

At the Research Center for Advanced Science and Technology, the University of Tokyo (RCAST) is pursuing interdisciplinary research covering key domains: information, biology, environment, material, universal-design and society. A sixth domain is biochemical medicine, and RCAST is trying to understand the mechanisms of diseases and pursuing R&D into new drugs.

Challenge

Pharmaceutical companies and research institutes around the world are eager to harness cutting-edge science and technology in their quest for new drugs.

Solution

The University of Tokyo has its own supercomputer and high-performance computing (HPC) cloud environment and decided to use Fujitsu’s cloud service for analytical simulations.

Benefit

  • Large-scale computing environment unconstrained by the power-consumption restrictions within the university campus
  • Scalability of the cloud means future needs can be met by simply adding computing resources as research expands